Source:http://linkedlifedata.com/resource/pubmed/id/16231190
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2005-11-28
|
pubmed:abstractText |
People exposed to beryllium compounds are at increased risk of developing beryllium sensitization and chronic beryllium disease (CBD). The purpose of this short communication is to present information regarding the potential importance of skin exposure to beryllium, an exposure and alternate immune response pathway to the respiratory tract, which has been largely overlooked in epidemiologic and exposure assessment studies.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0340-0131
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
79
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
161-4
|
pubmed:meshHeading | |
pubmed:year |
2006
|
pubmed:articleTitle |
Beryllium exposure: dermal and immunological considerations.
|
pubmed:affiliation |
Division of Respiratory Disease Studies, National Institute for Occupational Safety and Health, 1095 Willowdale Road, MS 2703, Morgantown, WV 26505-2888, USA. gdd2@cdc.gov
|
pubmed:publicationType |
Journal Article,
Review
|